Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial

Tanaka, Atsushi; Shimabukuro, Michio; Teragawa, Hiroki; Yoshida, Hisako; Okada, Yosuke; Takamura, Toshinari; Taguchi, Isao; Toyoda, Shigeru; Tomiyama, Hirofumi; Ueda, Shinichiro; Higashi, Yukihito; Node, Koichi; ,; Ako, Junya; Amano, Hirohisa; Hisauchi, Itaru; Ikehara, Yumi; Jinnouchi, Hideaki; Kawano, Yoshiyuki; Kimura, Kazuo; Kurozumi, Akira; Kusumoto, Takaaki; Machii, Noritaka; Maruhashi, Tatsuya; Matsuzawa, Yasushi; Misu, Hirofumi; Narisawa, Manabu; Ota, Tsuguhito; Oyama, Jun-ichi; Sakuma, Masashi; Shiina, Kazuki; Shima, Kosuke R.; Sugiyama, Seigo; Suzuki, Kunihiro; Takahashi, Naohiko; Takemoto, Yasuhiko; Takeshita, Yumie; Tamaki, Hiroshi; Tanaka, Kenichi; Tamura, Akira; Torimoto, Keiichi; Yamaoka-Tojo, Minako; Uehara, Hiroki; Uemura, Fumi; Yamakawa, Ken; Yufu, Kunio

doi:10.1038/s41440-024-01725-4

Hypertens Res

2024

DOI: 10.1038/s41440-024-01725-4

|View full text |Cite

Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial

Atsushi Tanaka,

Michio Shimabukuro,

Hiroki Teragawa

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases

Asanuma

2024

Hypertens Res

View full text Add to dashboard Cite

Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases

Asanuma

2024

Hypertens Res

View full text Add to dashboard Cite

Preface-risk of hypertension to cardiovascular disease and beneficial effects of drugs

Mogi,

Hoshide,

Kario

2024

Hypertens Res

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial

Cited by 2 publications

References 20 publications

Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases

Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases

Preface-risk of hypertension to cardiovascular disease and beneficial effects of drugs

Contact Info

Product

Resources

About